Sennosides Tablet, Chewable
NDC Package 79481-0860-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sennosides tablets is sennosides are used to treat constipation. This formulation utilizes a tablet, chewable delivery system. Marketed by Meijer, Inc., this product is identified by NDC 79481-0860 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
79481-0860-1
Package Description
24 TABLET, CHEWABLE in 1 CARTON
Product Code
79481-0860
11-Digit Billing Format
79481086001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sennosides
Non-Proprietary Name
Sennosides
Substance Name
Sennosides
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 15 mg/1
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Meijer, Inc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-15-2023
End Marketing Date
11-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 79481-0860-1 identifies a specific commercial package of 24 tablet, chewable in 1 carton of Sennosides, a human over the counter drug labeled by Meijer, Inc.. This tablet, chewable is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Meijer, Inc. on September 15, 2023.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Meijer, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 79481086001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
79481-0860-1
11-Digit CMS (5-4-2)
79481-0860-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.